• DigiMax now has $18 million in growth financing, including investment from H.C. Wainwright
• The company has expanded product offerings scheduled for launch throughout the second half of 2021
• DigiMax has plans to acquire strategic technologies to spur further growth
• The company has an expert AI team in place
• The AI industry has a five-year CAGR of 18.4%, with revenues projected to reach $37.9 billion by 2024

DigiMax Global (CSE: DIGI) (OTC: DBKSF) is an artificial intelligence technology and services company producing and leveraging predictive indicators across various industries and verticals. The company offers financial, business, and human capital AI predictive solutions to businesses, institutions, and consumers to improve decision-making. The DigiMax core solutions are:

1. CryptoHawk AI – CryptoHawk is a deep learning AI solution (“SaaS”) that monitors and analyzes live select cryptocurrencies and financial markets. The CryptoHawk AI solution is offered to retail clients as a monthly subscription. Generated data provides subscribers with price trend predictions for better investment strategies.
2. Cryptocurrency Hedge Fund – A long/short cryptocurrency hedge fund for high net worth, institutional, and family office clients was launched on September 1, 2021. The company’s crypto hedge fund earns clients’ management and overall performance fees.
3. Projected Personality Interpreter (“PPI”) – DigiMax solutions utilize AI to provide comparative insights for better hiring decisions, reduced employment attrition, improved workplace culture, and augmented human and financial predictive services by measuring and correlating personal attributes.
4. Navee Predict – DigiMax data scientists provide companies with the unprecedented power of enhancing decision-making by analyzing, detecting changes and forecasting patterns.

The company’s team has extensive experience in finance, trading, machine learning (“ML”), neural language processing, AI, big data, and cryptocurrency technology. DigiMax leverages AI and its expert team to translate data into actionable predictive insights across the financial, business, and human dimensions, enhancing the decision-making capacity of organizations. DigiMax is an official IBM Watson partner with more than 30 years in data science and artificial intelligence. Solutions Business and Financial Capital Solutions CryptoHawk AI CryptoHawk.ai is a cryptocurrency price and trend prediction solution offered as a web application (https://cryptohawk.ai) and a mobile application by the end of 2021. The value for the user is to capture gains and take advantage of volatility while reducing risk and engaging in smarter and simpler trading. The key features:

• Trend Prediction Indicator (“TPI”) The TPI is a superior model that leverages the cryptocurrencies analyzed by the AI and other market-driven data and policies to produce actionable predictions in the form of:

• Prediction cards
• Cryptocurrency graphs with optional market indicators
• Email/SMS alerts
• Trend Watch Trend Watch is a one-week look ahead machine learning prediction for a select portfolio of mature cryptocurrencies. Trend Watch predicts a trend being UP or DOWN and provides a price target. Users have access to:
  • A list of select cryptocurrencies with predictive graphs

The system alerts investors through email and text messages when a price trend changes, allowing users to act confidently. Cryptocurrency Hedge Fund On September 1, 2021, DigiMax launched its Cryptocurrency Hedge Fund to offer high net worth, institutional, and family office clients a fully systematic long/short active investment into a basket of cryptocurrencies capitalizing on crypto volatility and powered by proprietary trading algorithms. The official launch is expected in the coming months. The fund is led by 40-year hedge fund veteran Ian Hamilton and has an experienced investment and fund management team. This actively managed fund provides an excellent opportunity for larger investors to gain exposure to cryptocurrencies. AI Business Prediction as a Service The company offers predictive insights to businesses through automation and its innovative and proprietary AI and ML technology. Traditional models are expensive, because they are created and developed by data scientists dedicated to solving specific business questions that require costly customization and weeks, if not months, of development. With DigiMax, companies have access to solutions and services at a fraction of the price of traditional and experimental approaches. By combining AI with ML prediction technology, the company delivers insights on:

• Sales forecasts
• Optimal inventory levels
• Supply chain management
• Invoice payment projections
• Targeted segmentation for marketing campaigns

Human Capital Solutions AI-Powered Projected Personality Interpreter The Projected Personality Interpreter (“PPI”) evaluates and improves customers’ workforce, brand and culture by revealing the personality traits and sentiment buried in human expression. The PPI empowers organizations with comparative insight for better hiring decisions, reducing employment attrition and improving workplace culture. PPI provides a comprehensive and complete solution, offering:

• Recruitment campaign management
• Custom questionnaires, desirable traits recipes, and group likenesses
• Detailed personality reports to compare and contrast peers
• API for advanced integration with alternative systems of record

DigiMax leverages IBM Watson and a custom algorithm that analyzes applicant responses across 52 different traits and compares those scores with a baseline, providing hiring managers with a comprehensive report that improves decision making and takes the bias out of the process. The company’s solution is currently in use by 17 law enforcement agencies in North America and is used across the 10 global recruitment brands of Shepherd Search Group. Market Overview The AI industry has a five-year CAGR of 18.4%, with revenues projected to reach $37.9 billion by 2024. Some more optimistic forecasts have the market worth as much as $15 trillion by 2030. It’s estimated that 80% of all emerging technologies in 2021 have AI foundations. About 40% of all businesses use AI in their operations. According to Industry Ark, artificial intelligence use in the recruitment market was valued at $580 million in 2019. Management Team Chris Carl, CEO Chris Carl has over 20 years of experience as a public-company CEO and has built several successful businesses across multiple categories. He has a proven ability to lead and has a track record of execution, revenue growth, and value creation. Thierry Hubert, CTO Thierry Hubert has 30 years of technology experience with Fortune 100 companies worldwide and is an early pioneer in applying artificial intelligence to solve big data and unstructured information challenges with IBM as a Director of R&D in emerging technology, knowledge management, and process innovation. He has received awards, recognitions, and grants that contributed to his ongoing collaboration with industry leaders. David Bhumgara, CFO David Bhumgara is a senior finance executive with over 25 years of leadership experience and proven expertise in finance, financial reporting, accounting, corporate finance, budgeting, financial modeling, and mergers & acquisitions. Damon Stone, Trading Strategy Advisor Damon Stone is an experienced stock and crypto trader who works very closely with the Cryptodivine.ai data science team as a subject matter expert. During 15 years at Merrill Lynch as a market maker and proprietary trader, he traded many different sectors, culminating in heading up a $250 million trading desk. Ross Power, Senior Innovation Engineer Ross Power is an experienced technical system architect with a demonstrated history of working on advanced technologies, including AI algorithms, IoT solutions, 3D printing, Innovation in BCI (Brain-Computer Interfacing), and RC flight and navigation systems. For more information, visit the company’s website at https://digimaxglobal.com. NOTE TO INVESTORS: The latest news and updates relating to DBKSF are available in the company’s newsroom at https://ibn.fm/DBKSF

• BevCanna Enterprises Inc. is a diversified health & wellness beverage and natural products company, which offers in-house brands and provides white-label production and distribution solutions to its industry-leading partners
• BevCanna has recently announced tie-ups with Keef Brands as well as with The Tinley Beverage Company to produce and distribute their products within the Canadian continent

Functional drinks and drinks based on plant derivatives — particularly those containing cannabis- or hemp-derived ingredients like cannabidiol (“CBD”) or tetrahydrocannabinol (“THC”) — have rapidly established themselves as one of the fastest-growing verticals within the North American beverage industry, with a recent study forecasting the global cannabis drinks sector to triple in value to $5.8 billion by 2024. BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health & wellness beverage and natural products company developing and manufacturing a range of alkaline, plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients has sought to capitalize on the growing demand, most recently through its various collaborations with US cannabis-infused beverage manufacturers (https://ibn.fm/QaNnN). Surveys have shown that in U.S. states where cannabis is legal for recreational use, drinks make up 15 percent of purchased cannabis value, with one in four consumers remarking that they would be willing to try cannabis-infused drinks.  The strong growth trends witnessed in the U.S look particularly promising for the nascent Canadian cannabis-derived drinks market, with the sector poised for significant growth in the coming months and years. A key growth driver set to underpin future growth within the Canadian cannabis beverage market lays within the product selection currently available within the sector. BevCanna have sought to widen selection through the introduction of several leading US brands within the Canadian domestic market, capitalizing on their existing manufacturing facilities and nationwide distribution coverage.  In early August, BevCanna announced that they had successfully completed the first commercial production run of the leading U.S. beverage brand, Keef Brands’ cannabis-infused beverages, for delivery to select provincial distribution boards across Canada. “This inaugural run of Keef represents a significant milestone for BevCanna,” said Melise Panetta, president of BevCanna (https://ibn.fm/ADWHv). “We’re launching in multiple Canadian markets and are excited to be including this already well-known and loved cannabis brand among our first offerings. We expect that Keef will take a leadership position within the Canadian cannabis-infused beverage space” The company also announced on August 19 that it had signed a definitive agreement with The Tinley Beverage Company Inc. (CSE: TNY) (OTCQX: TNYBF) to co-manufacture its award-winning cannabis-infused beverages for the Canadian market. The agreement will see BevCanna produce and distribute Tinley’s full product portfolio which includes their line of ready-to-drink, adult beverage-inspired sparkling Tinley Classics, Tinley’s Tonics as well as their Moscow Mule-inspired Tinley’s Tonics High Horse, among various others. With U.S. beverage makers increasingly seeking to venture into Canada’s relatively under-penetrated cannabis beverage market, BevCanna’s white-label partnership model for Canadian production and distribution allows the company’s potential non-licensed partners to mark their initial forays into the Canadian cannabis market in a smooth and compliant manner. In addition, BevCanna’s broad distribution network, which features over 3,000 points of retail distribution spread across Canada, allows for companies to dramatically expand their retail footprint while subject to a single, seamless partnership. For more information, visit the company’s website at www.BevCanna.com. NOTE TO INVESTORS: The latest news and updates relating to BVNNF are available in the company’s newsroom at http://ibn.fm/BVNNF

Date: October 5-7, 2021 Virtual Event Free registration Typically, an expo aims to educate, describe the journey into a particular theme or topic, and create an interactive environment for all in attendance. As one such event, The Interactive MoneyShow Virtual Expo, scheduled for October 5 to 7 this year, promises to offer this and more, guided by the tagline “gain expert advice to position your portfolio for maximum profits in the year ahead!” The three-day event is meant for anyone and everyone looking to gain more insights into trading and investing – it aims to arm attendees with the information and tools needed to help make them more successful traders and investors. It will achieve this through live sessions, virtual booths, and networking opportunities. The live sessions, available for free from any streaming device and delivered by more than 60 of the country’s most sought-after investing and trading experts, will include real-time market analysis, timely portfolio advice, and recommendations from the pros. The sessions will also equip viewers with new strategies that empower them to deal with today’s market volatility. Furthermore, MoneyShow will optimize the sessions to maximize benefits to those in attendance by tagging the sessions with keywords as well as providing attendees with personalized recommendations based on their unique interests. The sessions will kick off at 10:00 AM ET on October 5 with a presentation from Dr. Alexander Elder, a trader and author of The New Trading for a Living. Later, at 10:40 AM, the Chief Investment Strategist at Ally Invest, Linsey Bell, will take the baton with her presentation, titled “Final stretch and looking into 2022.” Day 1 will come to a close at 6:00 PM, marking the culmination of a day of informative presentations from more than ten experts and setting the stage for the subsequent live sessions on Day 2 and 3. In their respective presentations, the experts will explore the following topics:

• How to profit from catalyst events in the stock market
• Building a system for trading psychology
• Investing for income in a low-yield environment
• How to spot major trend reversals with Elliott wave theory and socioeconomics
• Which high-yield dividend stocks will make it through the recovery?
• Time-proven 21st century strategies
• How to monetize market moves and take timely profits
• Ways to achieve tax savings as a trader
• The best investments for today’s top trends

The financial experts will go beyond this by sharing knowledge and experience on how they are adapting their strategies to capitalize on the market volatility and current market conditions. Attendees will also discover the experts’ recommendations on various financial instruments, including bonds, stocks, ETFs, futures, forex, options, and more. At the same time, the virtual booths – which, together, make up the virtual exhibit hall – will have attendees learn about the latest products from leading companies, as well as add investor kits, educational content (videos and articles), and research and analysis reports to their digital briefcases. At the virtual exhibit hall, attendees will get to enjoy exclusive discounts, win great prizes, as well as ask questions and schedule meetings with company experts through interactive message boards. In a world where networking is held to a high status, the Interactive MoneyShow Virtual Expo will facilitate interactions via live chats and message boards, enabling attendees to interact with experts and the global community of traders and investors. For more information, please visit https://ibn.fm/V7aGi

• reAlpha seeks to provide retail investors with fractional ownership in lucrative short-term rental properties
• The short-term rental market has seen a significant rise in popularity, with Airbnb recently releasing record revenues during its second-quarter results briefing
• reAlpha sees an opportunity to meet consumer demand by deploying as much as $1.5 billion to create a short-term rental property portfolio numbering close to 5,000 properties
• The company’s goal is to democratize investment access to the sector while simultaneously generating higher yields offered up by short-term rental properties

In early August 2021, Airbnb (NASDAQ: ABNB) reported second-quarter revenues that astounded the market. Revenues in the second quarter of 2021 came in at $1.34 billion, nearly four times higher than in the equivalent period in 2020, and up 10 percent over 2019. The quarter also heralded both Airbnb’s “strongest quarterly revenue on record” as well as its single “biggest” night of bookings. reAlpha is a cutting-edge technology company launching a platform to democratize the real estate market. The innovative startup plans to do so by providing retail investors with the ability to invest in the $1.2 trillion short-term rental market, capitalizing on the growing popularity of the Airbnb platform in diversified short-term rental property portfolios (https://ibn.fm/uE6mA). Dublin, Ohio-based reAlpha recently announced plans to spend as much as $1.5 billion, including debt, to build a unique and geographically diversified short-term rental portfolio, with reAlpha Chief Executive Officer, Giri Devanur stating that the deployed funds would be enough to purchase roughly 5,000 homes (https://ibn.fm/jzF9I). The company will employ proprietary artificial intelligence software to evaluate existing home listings and garner appropriate property valuations. Initially, the company will target specific cities in Florida, California, and Texas, where it can rapidly scale, acquiring between 100 to 500 homes. The company has also revealed that it will seek ways to lower its acquisition expenses, including potentially purchasing homes from the wholesale real estate market, which currently is only available to large-scale buyers. “We can analyze thousands of properties in a minute. For us, everything is through technology” Devanur said. A recent study from the University of California, Los Angeles (https://ibn.fm/3xxZI) sought to delve deeper into the historical total returns of single-family home rentals in the United States. The study, which covered a nearly 30-year period between 1986 and 2014, found that real estate investments delivered a near 8.5 percent total annualized return, comprising 4.2 percent rental income and 4.3 percent price appreciation. However, in certain locations, opting to rent out properties on a short-term basis could lead rental yields to more than double. Through its proprietary platform, reAlpha will seek to provide retail investors with access to the superior returns linked to short-term rentals as well as to the potential capital appreciation drawn from a combination of property renovations and market appreciation. Giri Devanur elaborated on the company’s objectives: “reAlpha enables superior alpha yield by investing in short-term rental properties. We have simplified the entire process of investing and managing these properties using advanced technologies. This allows ‘Mainstreet’ investors to access the real estate investment market like never before,” (https://ibn.fm/7KqwM). For more information, visit the company’s website at www.reAlpha.com. NOTE TO INVESTORS: The latest news and updates relating to reAlpha are available in the company’s newsroom at https://ibn.fm/reAlpha

• Medical cannabis reform in Brazil is slowly taking shape
• Challenges include the cost of medical cannabis products and medical cannabis patients living close to available access
• With its background in connected devices, big data, and technology, RYAH appears well qualified to provide insight on medical cannabis around the world

While the cannabis world’s attention is often focused on what’s happening in North America, activity in Latin America may be making significant progress. For example, a recent blog post (https://ibn.fm/t36SM) from RYAH Group (CSE: RYAH) states that “Brazil, one of the region’s largest markets, is quietly, if incrementally, making advances toward a powerful medical cannabis program.” The blog, titled “Past, Present, and Future: Medical Cannabis in Brazil,” notes that “medical cannabis in Brazil may face some steep political hurdles, but the waves of reform are slowly making it possible for more patients to access more medicine.” The largest South American country both in size and population, Brazil boasts a GDP per capita of $15,388. “At the time of writing, there are several different estimates about the number of people currently authorized as medical cannabis patients,” the article continued. “For example, there may be 14,500 or more patients served by the country’s only legal patient association and 20,000 more citizens approved to import products into the country.” Observing that it’s unclear if there is any overlap in those numbers, the article explains three ways medical cannabis patients can obtain cannabis in the country: through a pharmacy, patient association, and imports. “For most patients in Brazil, medical cannabis products are far too expensive, and few people live close enough to the only patient association, ABRACE, to access more affordable options,” the blog explains. “Furthermore, unlike the medicinal options available in other countries, the Brazilian program primarily focuses on high-CBD, low-THC options.” While the country has faced challenges, RYAH notes that Brazil seems poised at the top of a crest. “Slow legislative reforms have been building for years, gradually offering patients more options for medical cannabis,” the article states. “But the country isn’t quite there yet. A few additional pieces need to fall into place to finally open the flood gates, including legalizing the local cultivation of medical cannabis and hemp. With the current political climate in the country pushing against the tide, it remains uncertain when this legislation will finally come to pass.” With its background in connected devices, big data, and technology, RYAH appears well qualified to provide insight on medical cannabis around the world. The company was granted the first patent granted in AI data analytics in plant-based medicine and owns one of the largest plant-based medicine databases in the world with more than 200,000 registered users. In addition, the company’s multiple IoT device portfolio is designed to capture a broader patient demographic and the clinical trial market. For more information, visit the company’s website at www.RYAHGroup.com. NOTE TO INVESTORS: The latest news and updates relating to RYAH are available in the company’s newsroom at https://ibn.fm/RYAH

• Recent DSA study reported that the direct-selling channel generated $40.1 billion in retail sales in 2020, an increase of 13.9% from the previous year
• Study shows that direct-selling companies adapted quickly to a changing world by empowering their independent sellers
• SHRG’s The Happy Co. launched in February 2021 and offers functional beverages, capsules, patches and creams

Direct sales grew almost 14% last year in the United States, according to the most recent Direct Selling Association report (https://ibn.fm/T611K). Sharing Services Global (OTCQB: SHRG), a publicly traded company specializing in the direct-sales sector, stands to benefit from this trend, especially as the company focuses on innovating its direct-sales efforts, including the rebranding of its subsidiary operating in this space. The DSA study reported that the direct-selling channel generated $40.1 billion in retail sales in 2020, an increase of 13.9% from the previous year. The study also noted that the number of people selling products or services using the direct-selling model also increased, posting 13.2% growth, with 7.7 million U.S. entrepreneurs working part-time or full-time. Numbers also show that demand for direct-selling products is growing,with 41.6 million preferred customers and discount buyers purchasing through the direct-sales channel in 2020. “U.S. Direct Selling Association (‘DSA’), the national trade association for companies that offer entrepreneurial opportunities to individuals who choose to sell products and services direct to customers, released its Direct Selling Growth and Outlook Survey results for 2020 today, showing double-digit growth in retail sales, direct sellers, and customers of the channel,” reported a recent DSA article. “Growth & Outlook is DSA’s annual survey that reports on the size and scope of direct selling in the U.S. and is audited by Nathan Associates, a third-party international economic consulting firm.” The article went on to quote DSA president Joseph N. Mariano, who stated that “America is forever changing, no more so than during the last year. Direct sellers have proven themselves time and again to be nimble microentrepreneurs, willing and able to serve their customers and communities within a changing environment. “The direct selling companies also adapted quickly to a world with changing needs by empowering their independent sellers with the tools to serve their customers and fellow sellers – innovative technology, updated health and safety policies, and second-to-none business support,” he continued. “During this time of uncertainty, Direct Selling Association and its members also worked to ensure that customers and salespeople alike can rely upon the highest level of business ethics.  The results are clear — a record-breaking year and an unequivocal demonstration that direct selling is dedicated to serving America.” Paul Bourquin, principal at Nathan Associates, said, “Since 1995, Nathan Associates has been proud to work with the DSA analyzing the Growth & Outlook Survey data and conducting extensive secondary research to develop industry-wide estimates for the U.S. direct selling industry. As a third-party international economic consulting firm, we deliver methodologically sound industry wide estimates to help DSA serve as a trusted source of data on the full direct selling channel in the U.S.” SHRG’s The Happy Co. launched in February 2021 and offers functional beverages, capsules, patches and creams that elevate mood, boost energy, reduce stress, enhance sleep, increase muscles, minimize fat and tighten skin, and make users look, feel and perform like a younger person. The products are nootropics, or nutraceutical formulations derived from food sources that provide health benefits above and beyond basic nutritional value. Sharing Services Global Corporation is dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products and technologies. The Sharing Services combined platform leverages the capabilities and expertise of various companies that market and sell products direct to the consumer. Its primary division includes Elevacity U.S. LLC, the parent company of the Happy Co. and a sales and marketing company based on utilization of independent contractors as the sales force. For more information, visit the company’s websites at www.SHRGInc.com and www.TheHappyCo.com. NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

• Home Health and Diabetes Care Program helps suppliers present their offerings to buyers from major US chains actively searching for new products to sell
• InnerScope raised buyers’ interest as the only company presenting direct-to-consumer hearing products; scheduled 50 one-on-one meetings with corporate buyers from major US retailers
• Company is poised to forge key strategic relationships to build robust distribution network with industry-leading partners

InnerScope Hearing Technologies (OTC: INND), an emerging disruptive leader in the direct-to-consumer hearing technology space, participates in the virtual Home Health & Diabetes Care Program — an event that connects sellers and corporate buyers (https://ibn.fm/XCtPR). With its unique technology that customers can use from the comfort of their homes, InnerScope is the only company from the hearing device and hearing healthcare category to present at the event. The Company is able to showcase its broad range of hearing aids and accompanying products to corporate buyers from the home health care sector, but also to pitch its offering to buyers from the diabetes healthcare space since hearing impairment is often associated with this disease—hearing loss is twice as frequent in diabetes patients as it is in those who don’t suffer from it (https://ibn.fm/ApqHt). The event running from Sept. 20–23, 2021, is intended to drive business opportunities for presenting companies by ensuring they get in front of the right people at the right time to make a sale and build a lasting business relationship. Acting as a bridge between buyers and suppliers, the virtual Home Health and Diabetes Care Program features some of the biggest names in the healthcare consumer products category. The Program provides InnerScope with a unique opportunity to demonstrate its unmatched direct-to-consumer hearing devices and hearing health products to 50 corporate buyers from some of the largest US retailers, including industry heavyweights such as CVS and Kroger Costco, H-E-B, QVC, AmerisourceBergen, McKesson, and more. During the event, the Company aims to demonstrate its broad range of hearing products, including Bluetooth app-controlled self-adjusting hearing aids and personal sound amplifiers products, as well as doctor-formulated dietary hearing and tinnitus supplements, and assorted ear and hearing health-related products. In over 50 one-on-one meetings slated for this virtual event, InnerScope hopes to forge important strategic relationships building its retail and wholesale distribution network among industry-leading partners. As a company empowering consumers to take control of their hearing healthcare, InnerScope aims to position itself as a go-to provider for all things hearing-related. Unmatched within the direct-to-consumer hearing aid products, the Company is able to showcase its disruptive innovative products while highlighting its unique selling proposition and revealing its distinctive journey towards becoming a leading direct-to-consumer disruptor within the hearing device space. For more information, visit the company’s website at www.INND.com and the company’s e-commerce website: www.MyHearIQ.com. NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

• StorEn issued ANYSeed a convertible note in 2019; the fund recently converted the note into equity
• ANYSeed supports science and technology-based, early-stage ventures located in downstate New York
• Focused on offering innovative battery storage, StorEn Technologies is leading way in the development of evolutionary vanadium flow batteries

StorEn Technologies, a developer of evolutionary vanadium flow batteries with a disruptive patent-pending, all-vanadium flow battery technology, has announced that Accelerate New York Seed Fund (ANYSeed) has become a shareholder (https://ibn.fm/vJewK). “Over three years ago, in March of 2019, we raised funds from ANYSeed and issued them a convertible note after receiving the financing,” StorEn announced. “If you’re not familiar with how convertible notes work, they are a popular fundraising instrument, a hybrid of debt and equity. They are structured as loans with the option of converting to equity, as opposed to requesting the repayment of the principal plus accrued interest. “We’re so grateful to ANYSeed for converting their note into equity,” the announcement continued. “Thank you for supporting our enduring progress in the path to volume manufacturing. . . . With the help of all our shareholders, like ANYSeed, we are striving to make StorEn a success.” In partnership with Empire State Development, the Accelerate NY Seed Fund supports science and technology-based, early-stage ventures located in downstate New York (https://ibn.fm/OD9ps). The fund’s mission is to facilitate the transition from laboratory research and ideas into products, processes and services that deliver a financial return to investors. The fund considers projects in the biopharma, materials, tech, med tech, healthcare and energy sectors, with a strong preference for research institution affiliation and intellectual property strength. With its strong tie to Stony Brook University in New York, StorEn Technologies fits the bill perfectly. Focused on offering innovative battery storage for the 21st century, StorEn Technologies is leading the way forward in the development of evolutionary vanadium flow batteries. The battery pioneer is currently in the middle of a Reg A offering, creating a unique opportunity for investors interested in the future of battery storage. StorEn is currently in the process of a RegA offering with four different investment tiers; each tier offers a different discount and reward (https://ibn.fm/E4IcJ). With a proprietary product that answers the call for long-lasting, 100% recyclable, safe and affordable energy storage, StorEn and its disruptive, patent-pending, all-vanadium flow battery technology for energy storage holds real promise in a growing market. The company has developed evolutionary vanadium flow batteries. Incubated at the Clean Energy Business Incubator Program (“CEBIP”) within Stony Brook University in New York, the company is building upon the strengths of vanadium flow batteries to revolutionize the world of residential and industrial energy storage. In part, StorEn’s technology has enhanced the electrical efficiency of the stack and energy density of the electrolyte and module, ultimately reducing costs and improving performance. The company produces products with a battery life of 25 years and more than 15K cycles. That company takes pride in offering batteries that meet consumers demand for efficient, durable and cost-effective energy storage, enabling self-consumption of self-produced electricity and the transition toward a carbon-free economy. For more information, visit the company’s website at www.StorEn.tech. NOTE TO INVESTORS: The latest news and updates relating to StorEn Technologies are available in the company’s newsroom at https://ibn.fm/StorEn

• Nemaura Medical is a medical technology company focused on developing non-invasive wearable diagnostic devices
• The company recently revealed its participation at the annual H.C. Wainwright Global Investment Conference, held between September 13-15, 2021
• Through its sugarBEAT flagship product, Nemaura has sought to capitalize on the expanding Type 2 Diabetes market, expected to reach an annual value of $59 billion by 2025

Nemaura Medical (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs; the company’s flagship product, the sugarBEAT(R), is a wearable, non-invasive and flexible Continuous Glucose Monitor designed to help people with diabetes and prediabetes manage their glucose levels. Nemaura Medical’s management recently revealed their attendance at the 23rd Annual H.C. Wainwright Global Investment Conference, held in an entirely digital forum between September 13-15, 2021 (https://ibn.fm/1OiBy). Initially founded in 1868, H.C. Wainwright is a U.S.-based investment bank offering leading-edge investment banking, corporate finance, and strategic advisory services to public and private growth companies across multiple sectors and regions. The 23rd Annual H.C. Wainwright Global Investment Conference (https://ibn.fm/x6vUI) featured over 850 corporates in attendance, distributed across six distinctive sector tracks, namely – healthcare & life sciences; metals & mining; cryptocurrency, blockchain, & fintech; cleantech; technology, media & telecommunications; as well as shipping & maritime. In addition, the conference featured some of the industry’s leading keynote speakers, one-on-one investor meetings, and networking opportunities with attendees. H.C. Wainwright’s annual investment conference routinely attracts some of North America’s largest institutional investors, private equity firms, and venture capitalists seeking new investment opportunities. Over 420 million people globally are currently living with diabetes, with prediabetic cases totalling almost three times that number. In the US alone, over $760 billion was spent on diabetes-related health care expenditures during 2019, equating to an average annual spend upwards of $9,000 per diabetic patient compared to approximately $1,600 for a healthy individual (https://ibn.fm/Fzjhi). Combining clinical research with patient-friendly technology and through its sugarBEAT product, Nemaura Medical seeks to provide a non-invasive, affordable, and flexible method of blood glucose tracking for improved diabetes management. NMRD has positioned itself at the intersection of the global Type 2 diabetes market, which is expected to reach an annual value of nearly $59 billion by 2025. Moreover, the product also allows the company to participate in the $50-plus billion prediabetic market and the wearable health-tech sector for weight loss and wellness applications, which is forecast to hit $60 billion by 2023. For more information, visit the company’s website at www.NemauraMedical.com. NOTE TO INVESTORS: The latest news and updates relating to NMRD are available in the company’s newsroom at https://ibn.fm/NMRD

• WHO survey reports that mental health services in 93% of countries around the world have been disrupted or halted as a result of COVID-19
• People with pre-existing mental, neurological or substance-use disorders are more vulnerable to SARS-CoV-2 infection
• Cybin is on a mission to revolutionize mental healthcare

A World Health Organization (“WHO”) survey covering 130 countries is calling attention to the fact that today’s demand for mental health, which has been rocked by the COVID-19 pandemic, is only increasing (https://ibn.fm/hzmXq). Cybin (NEO: CYBN) (NYSE American: CYBN) is focused on meeting that need and is committed to finding even more effective ways to help those struggling with mental health issues. “The COVID-19 pandemic has disrupted or halted critical mental health services in 93% of countries worldwide while the demand for mental health is increasing, according to a new WHO survey,” a WHO news release reported. “The survey of 130 countries provides the first global data showing the devastating impact of COVID-19 on access to mental health services and underscores the urgent need for increased funding.” The release goes on to note that the underfunding of mental health issues is nothing new. “Prior to the pandemic, countries were spending less than 2% of their national health budgets on mental health, and struggling to meet their populations’ needs,” the release pointed out. “And the pandemic is increasing demand for mental health services. Bereavement, isolation, loss of income and fear are triggering mental health conditions or exacerbating existing ones. “Many people may be facing increased levels of alcohol and drug use, insomnia, and anxiety. Meanwhile, COVID-19 itself can lead to neurological and mental complications, such as delirium, agitation, and stroke. People with pre-existing mental, neurological or substance use disorders are also more vulnerable to SARS-CoV-2 infection — they may stand a higher risk of severe outcomes and even death.” The report quotes the director-general of WHO, Dr. Tedros Adhanom Ghebreyesus. “Good mental health is absolutely fundamental to overall health and well-being. COVID-19 has interrupted essential mental health services around the world just when they’re needed most. World leaders must move fast and decisively to invest more in life-saving mental health programs — during the pandemic and beyond.” The survey only underscores the work that Cybin is doing. This game-changing company is keenly aware that more than 700 million people around the world are impacted with some sort of mental illness, addiction or eating disorder, and the company is on a mission to revolutionize mental healthcare. The innovative organization is focused on leveraging its expertise in the psychedelic therapeutic space to deliver proprietary drug-discovery platforms, innovative drug-delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders. “We are focused on addressing the mental health crisis and transforming the treatment landscape,” the company’s website states. “To do that, we are combining technology and our scientific expertise to pair novel psychedelic molecules with controllable drug delivery systems, aimed at improving outcomes for patients.” For more information, visit the company’s website at www.Cybin.com. NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN